<?xml version="1.0" encoding="UTF-8"?>
<p id="Par57">This review shows a need to strengthen global collaborations and investments to strengthen research capacity and capability, targeting regions prone to and vulnerable to epidemics in inter-epidemic times. Progress has been made in some areas. The UK NIHR portfolio of ‘hibernating’ pre-approved protocols [
 <xref ref-type="bibr" rid="CR86">86</xref>], the global research collaboration for infectious disease preparedness [
 <xref ref-type="bibr" rid="CR8">8</xref>] and the WHO blueprint for R&amp;D into high-threat pathogens [
 <xref ref-type="bibr" rid="CR87">87</xref>] are steps in the right direction. However, the latter does not include pandemic influenza, and the WHO public health research agenda for influenza does not constitute a strategic plan of action [
 <xref ref-type="bibr" rid="CR88">88</xref>].
</p>
